Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities

Since nivolumab significantly prolongs survival in patients with metastatic melanoma, the number of patients administered nivolumab is increasing, but only 30–40% of patients who received nivolumab monotherapy experienced objective tumor regression. Therefore, enhancing its anti-tumor immune respons...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case Rep Oncol
Hauptverfasser: Furudate, Sadanori, Fujimura, Taku, Kambayashi, Yumi, Hidaka, Takanori, Hashimoto, Akira, Aiba, Setsuya
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2016
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118831/
https://ncbi.nlm.nih.gov/pubmed/27920696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450974
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge